HCV Treatment Initiation in Patients with Chronic Kidney Disease: Results from ERCHIVES

BACKGROUND: Newer directing antiviral agents against HCV (DAAs) are safe and efficacious in persons with chronic kidney disease (CKD). Whether availability of these newer DAAs has resulted in more persons with CKD initiating HCV treatment remains unknown. METHODS: We identified HCV+ persons in ERCHI...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Butt, Adeel, Ren, Yanjie, Puenpatom, Amy, Arduino, Jean Marie, Kumar, Ritesh, Abou-Samra, Abdul-Badi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632023/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.384
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi